Crossmark

Low-grade oncocytic tumor of kidney harboring TSC/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity

Crossref DOI link: https://doi.org/10.1007/s00428-022-03283-x

Published Online: 2022-01-31

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Hui-Zhi

Xia, Qiu-Yuan

Wang, Shu-Yan

Shi, Meng-Jie

Wang, Su-Ying
License Information

Text and Data Mining valid from 2022-01-31

Version of Record valid from 2022-01-31
More Information

Article History

Received: 19 November 2021

Revised: 14 January 2022

Accepted: 19 January 2022

First Online: 31 January 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below